Skip to main content
P&T COMMUNITY
Register
Sign in
Search form
Search
Home
News
P&T
Current issue
Past issues
Contact us
Digital Edition
Subscribe
P&T TV
Dr. David B. Nash
Meeting Highlights
Authors
About
Contact Us
News
P&T Journal
Formulary Kits
INGREZZA®
(valbenazine) tablets
KEDRAB™
(Rabies Immune Globulin [Human])
LOKELMA™
(sodium zirconium cyclosilicate) 10 g for oral suspension
PERSERIS™
(risperidone) for extended-release injectable suspension
SUBLOCADE™
(buprenorphine extended-release) Injection for Subcutaneous Use (CIII)
Please
click
for full Prescribing Information, including Boxed Warning.
You are here
Home
News by month %2 2015
News by month February 2015
PTCommunity News February 2015
Surgeon Suggests Ways to Perform Human Head Transplants
CDC Committee Reaffirms Recommendation for Annual Influenza Vaccination
Daclatasvir/Sofosbuvir Combo Shows Promise in Hepatitis C Patients Co-Infected With HIV
FDA Approves Ebola Test for Emergency Use
Five Things to Know About Supreme Court Case Challenging Affordable Care Act
Cystic Fibrosis Discovery May Lead to New Treatment Strategy
Report: Competition Among Physicians and Retail Clinics Drives Up Antibiotic Prescribing Rate
Once-Daily Basal Insulin Toujeo Wins FDA Nod
FDA Approves Antibacterial Drug Avycaz (Ceftazidime/Avibactam)
Supreme Court Decision on Insurance Subsidies Could Trigger Price Spikes
Researchers Test ‘Breakthrough’ Pediatric Leukemia Treatment
Could HIV Drug Beat Strep Throat, Flesh-Eating Bacteria?
FDA Accepts New Drug Application for Extended-Release Hydrocodone Tablets With Abuse-Deterrence Technology
Eribulin (Halaven) Improves Survival in Sarcoma Study
Nationwide Recall of Atracurium Besylate Injection
Inhaled Dry-Powder Vancocymcin (AeroVanc) Reduces MRSA in Cystic Fibrosis Patients
Quick Test for Ebola Virus
Opioid Pain Reliever Abuse Called Top Public Health Challenge
Farydak (Panobinostat) Gets FDA Nod for Treatment of Multiple Myeloma
Fancy Flourishes at Hospitals Don’t Impress Patients, Study Finds
Positive Results Reported for Oral Semaglutide in Diabetes Patients
Asthma Drug Tiotropium Improves Lung Function in Phase III Trials
FDA Approves Closure System to Permanently Treat Varicose Veins
CDC Issues Measles Advisory
Obama Administration Disallows Health Plans Without Hospital Coverage
Study: Women With Multiple Sclerosis May Have Lower Levels of Key Nutrients
First Direct-to-Consumer Genetic Test for Rare Disorder Wins FDA Nod
FDA Warning: Duodenoscope Design May Impede Effective Cleaning
Safety and Efficacy of Statins Have Been Exaggerated, Scientists Say
Gilead Has Effective HIV Pill, But Few People Know About It
Ranibizumab (Lucentis) Reverses Vision Loss Caused by Diabetes
New Nanogel for Drug Delivery
Stanford Study Shows Rural Disadvantages Under Affordable Care Act
Scientists Develop Anti-HIV Agent Powerful Enough to Work in a Vaccine
‘Superbug’ Linked to Two Deaths at UCLA Hospital; 100 Potentially Exposed
Generic Lovenox and Generic Zyvox Launched in U.S.
Positive Results Reported for Eliglustat (Cerdelga) in Treatment-Naïve Patients With Gaucher Disease Type 1
Science Behind Commonly Used Antidepressants Appears to Be Backwards, Researchers Say
FDA Approves New Use for Cancer Drug Lenalidomide (Revlimid)
CVS Concerned About Potential Impact of New Cholesterol Drugs on Health Care System
Lung Cancer Drug Motesanib Fails Late-Stage Trial
FDA Grants Priority Review to Heart Failure Treatment
Alirocumab Lowers LDL-Cholesterol in Phase III Study
New Therapeutic Target for Multiple Sclerosis
Company Resubmits Women’s Libido Pill to FDA
Promising Results for New Alzheimer’s Therapy
Study Identifies Patients at Higher Risk of Second Stroke
Oral Eliglustat (Cerdelga) Scores in Treatment of Gaucher’s Disease
FDA Approves Lenvatinib (Lenvima) for Thyroid Cancer
Popular Painkiller Ketorolac in Short Supply at Hospitals After Recall
Making a Better Wound Dressing — With Fish Skin
Tobacco May Cause More Deaths than Currently Estimated
FDA Advisory Committees to Review Talimogene Laherparepvec for Metastatic Melanoma
JAMA Editorial Questions Medicare’s Approach to Tying Hospital Quality Measurement to Financial Penalties
2015 Could Be 'Year of the Health Care Hack,' Experts Warn
A New Name for Chronic Fatigue Syndrome?
Reolysin Receives ‘Orphan Drug’ Designation for Ovarian Cancer
FDA Approves Finafloxacin Otic Suspension
New Stroke VTE Safety Recommendations
Company Clears Up Exparel-Related FDA Warning Letter
Oral Ixazomib Improves Survival in Late-Stage Myeloma Trial
Predicting Disability and Death After the ICU
FDA Reviews Possible Risks of Pain Medications During Pregnancy
Drug Combo Kills Hepatitis C Virus Within 6 Weeks
Young Companies Look to Shake Up Global Glaucoma Market
Lucentis Approved to Treat Diabetic Retinopathy in Patients With Diabetic Macular Edema
Gene Therapy Market Could Reach $13 Billion in 10 Years, Report Says
Many Mastectomy Patients With Locally Advanced Breast Cancer Do Not Get Post-Op Radiation
Drug Combination Knocks Out HCV in Six Weeks During Phase II Trial
FDA Clears System to Reduce Stroke Risk During Stent and Angioplasty Procedures
Fast-Acting Human Insulin, HinsBet, Shows Promise in Mid-Stage Trial
Coffee Intake May Lower Endometrial Cancer Risk
Dabrafenib/Tametinib Improves Survival in Phase III Melanoma Study
After Hospital Discharge, Deadly Heart Risks Can Remain for Up to a Year
CMS Approves Medicare Coverage for Lung Cancer Screening
Tiny Robotic ‘Hands’ Could Improve Cancer Diagnostics, Drug Delivery
Study: Unnecessary Antibiotics Often Prescribed for Respiratory Infections in Outpatient Settings
FDA Approves First Tissue Adhesive for Internal Use
Free From Ebola, Survivors Complain of New Syndrome
More Expensive Emergency Care Yields Better Results
CDC Report: 58 Million Nonsmokers in U.S. Are Still Exposed to Secondhand Smoke
Biosimilar Candidate Is Equivalent to Adalimumab in Phase III Arthritis Trial
FDA Approves Breast Cancer Drug Ibrance (Palbociclib)
Company Announces New Class of Agents for Cystic Fibrosis
Medical Debt Still a Problem Under Affordable Care Act
Study: Metformin May Lower Lung Cancer Risk in Diabetic Nonsmokers
Cost of Having Diabetes Has Doubled in Two Decades
Sanofi Launches Only Inhaled Insulin for Diabetics
Reducing Hospital Readmission Rates Will Require Community-Focused Efforts
FDA Expands Use of Vyvanse (Lisdexamfetamine) to Include Treatment of Binge-Eating Disorder
HHS Issues ‘Road Map’ for Improving Electronic Health Information
FDA Approves Pazeo (Olopatadine) Solution for Ocular Allergy Itch Relief
‘Smart’ Devices Track Hand-Washing in Hospitals to Help Reduce Spread of Infection
Glyxambi (Empagliflozin/Linagliptin) Wins FDA Nod for Treatment of Type-2 Diabetes in Adults
